je.st
news
Tag: investigating
U.K. ISP TalkTalk Investigating Major Cyber Attack
2015-10-23 21:02:41| PC Magazine Security Product Guide
According to the BBC, CEO Didi Harding received a ransom email demanding money.
U.K. ISP TalkTalk Investigating Major Cyber Attack
2015-10-23 17:58:55| PC Magazine Software Product Guide
According to the BBC, CEO Didi Harding received a ransom email demanding money.
Come Heller high water: Flint's Watergate needs investigating
2015-10-21 18:16:38| Waste Management - Topix.net
Like the original Watergate scandal, Flint's own " Watergate " grows worse and worse. Now we learn: A) The feds told the state last winter that river water was corroding pipes and leaching contaminants, and B) The state followed the wrong testing standards.
Tags: high
water
investigating
heller
Serious Fraud Office investigating infant milk powder exporter
2015-10-18 22:24:15| Biotech - Topix.net
The Serious Fraud Office is investigating an exporter of infant milk powder and manuka honey that receivers say collapsed owing more than $1 million. Nubiotics, owned and directed by Waikato businessman Trevor Lock, entered receivership and liquidation in August last year, after falling behind on payments to boutique lender Waikawau Finance.
Tags: office
fraud
milk
powder
Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda (pembrolizumab) as First-line Treatment for Advanced Melanoma
2015-10-13 13:30:03| Merck.com - Product News
Dateline City: WILMINGTON, Del. and KENILWORTH, N.J. Pivotal study to evaluate Incytes IDO1 inhibitor in combination with Mercks anti-PD-1 therapy in patients with advanced or metastatic melanoma WILMINGTON, Del. and KENILWORTH, N.J. -- Incyte Corporation (Nasdaq: INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the expansion of the companies ongoing clinical collaboration to include a Phase 3 study evaluating the combination of epacadostat, Incytes investigational selective IDO1 inhibitor, with Keytruda (pembrolizumab), Mercks anti-PD-1 therapy, as first-line treatment for patients with advanced or metastatic melanoma. Language: English read more
Tags: for
advanced
include
study
Sites : [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] next »